What's new

India cancels order for 'faulty' China rapid test kits

Lego Jangkar

FULL MEMBER
Joined
Nov 26, 2017
Messages
114
Reaction score
0
Country
Indonesia
Location
Malaysia
India has cancelled orders for about half a million coronavirus rapid testing kits from China after they were found to be "faulty".

Delhi has also withdrawn the kits that were already in use in several states.

The kits take around 30 minutes to deliver a result and are supposed to detect antibodies in the blood of people who may have had the infection.

They help officials quickly understand the scale of infection in a particular area. China disputes India's claims.

"The quality of medical products exported from China is prioritised. It is unfair and irresponsible for certain individuals to label Chinese products as 'faulty' and look at issues with pre-emptive prejudice," Chinese embassy spokesperson Ji Rong said in a statement issued on Tuesday.

The rapid testing kits cannot test for coronavirus itself and several scientists have raised concerns over their use for diagnosis.

Various Indian states had been pushing the Indian Medical Research Council (ICMR) to allow testing with the kits amid concerns that India was not testing anywhere close to enough.

The ICMR was initially reluctant, but cleared the way, importing the kits from two Chinese companies.

Soon after however, states began complaining that the kits had an accuracy rate of only 5%, adding that they had used the kits on patients who they already knew were positive, but the tests had shown a "negative" result for antibodies.

The test kits then also failed quality checks by the ICMR.

On Monday, the issue was further complicated after the Delhi high court capped the price of the tests and suggested that the government had overpaid.

However, officials have told local media that the government will "not lose a single rupee" from cancelling the order kits as they had not paid the amount in advance, and had cancelled the entire shipment.

https://www.bbc.com/news/amp/world-asia-india-52451455
 
Last edited:
I think "rapid test' kits from anywhere are not that accurate.
 
It takes 8 hours to get results at Beijing airport, and they have the best testing in the country. I don't know where India is ordering these "rapid" kits from.
Similar case happened when Canada ordered PPE. The equipment was expired. Defects here and there will always occur.
 
On USA designed flu vaccines from 2012:

Based on published literature, the efficacy (real world protection from influenza) is approx. half to two thirds of this, or approx. 25-35%. Only one third of vaccine recipients will gain true protection from influenza; and that is a best case estimate which is only true if the vaccine is a perfect match to the seasonal flu viruses that form the epidemic. This is right in the manufacturer's white sheet insert. In short, the very justification for mandating the vaccine in health care workers (i.e. to protect patients) is based on a false premise (i.e. the assumption that the vaccine is highly effective in preventing influenza infection, which according to the manufacturer it is not).


Any epidemiologist worth his salt will tell you that 35% efficacy for a vaccine is virtually worthless for preventing spread of influenza virus. I am astounded that doctors and hospitals are mandating what is effectively a placebo – it will have no significant impact on influenza infections in the hospital staff.
 
It takes 8 hours to get results at Beijing airport, and they have the best testing in the country. I don't know where India is ordering these "rapid" kits from.

Some South Korean companies are supplying and manufacturing them in India.
 
China embassy say these products are certified.

Indian need to give evidence on why it failed.

On the other hand, massive corruption and markup have been exposed on Indian PPE purchase from China.





http://in.china-embassy.org/eng/gdxw/t1773987.htm
We are deeply concerned with the evaluation results and the decision made by Indian Council of Medical Research. China attaches great importance to the quality of exported medical products. Recently, Chinese Embassy in India has maintained close contact with ICMR and the two Chinese companies to find out the real situation.

We have noticed that Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics already issued statements on this issue. They both stressed that their COVID-19 antibody rapid test kits had obtained the certification from the National Medical Products Administration of China (NMPA), meet the quality standards of China and exported countries, and have also been validated and approved by ICMR through National Institute of Virology (NIV), Pune and considered as satisfactory products. The COVID-19 antibody rapid test kits produced by these two Chinese companies have been exported to and well recognized in many countries in Europe, Asia and Latin America.
 
Back
Top Bottom